US Attorney General Sessions Signals Change in Marijuana Policy

US Attorney General Sessions Signals Change in Marijuana Policy

US Attorney General Sessions Signals Change in Marijuana Policy

  • USAG Sessions signals changes in federal marijuana enforcement policy
  • Senator Elizabeth Warren challenges Trump’s HHS nominee on medical marijuana and opioids,
Attorney General Sessions is making news on both the Marijuana and the Opioid fronts.

Marijuana Policy

Sessions Hints at Changes in Federal Marijuana Enforcement. At a press conference last Wednesday on new measures to address opioid use, Attorney General Jeff Sessions signaled that the Justice Department’s laissez-faire approach to marijuana in states where it is legal may soon be changing.

Justice is looking “very hard right now” at The Cole Memo, an Obama-era guidance to federal prosecutors that told them to generally make enforcement a low priority in legalization or medical states,

AG Sessions said. “We had meetings yesterday and talked about it at some length. It’s my view that the use of marijuana is detrimental, and we should not give encouragement in any way to it, and it represents a federal violation, which is in the law and it’s subject to being enforced, and our priorities will have to be focused on all the things and challenges we face,” he said. “We’ll be working our way through to a rational policy. But I don’t want to suggest in any way that this department believes that marijuana is harmless and people should not avoid it.”

Connecticut Gubernatorial Candidates Support Legalization. In the 1st debate of the 2018 gubernatorial campaign last Tuesday night, several candidates said they supported marijuana legalization, a step current Gov. Dannel Malloy (D) has been unwilling to take.

“Yes, I will sign a bill to legalize it,” said Democrat Dan Drew. “There are an awful lot of people who use cannabis for a variety of reasons… wouldn’t it be better if we control the process on the front end, if we were able to regulate it?”

Another Democrat, former consumer protection commissioner Jonathan Harris also said he supports marijuana legalization.

Republican candidate Prasad Srinivasan said he had concerns about public safety and public health.

San Francisco Approves Legal Marijuana Regs; Sales to Begin January 5. The Board of Supervisors voted Tuesday to approve regulations for recreational marijuana sales and set January 5 as the date when legal sales could begin. Supervisors voted for a 600-ft buffer between stores and schools much less than what some members of the Chinese immigrant community had lobbied for, and rejected provisions that would have let neighborhoods limit the number of pot shops or ban them outright.

Medical Marijuana

Senator Elizabeth Warren (D-MA) has sent a letter to Alex Azar, President Trump’s nominee to lead the US Department of Health and Human Services (HHS) suggesting the administration study how marijuana legalization could reduce opioid addiction and overdose deaths. The letter also asks Azar to answer questions about what he would do to study marijuana as an alternative to opioids, whether he is committed to implementing evidence-based policies, and what steps he would take to “improve our knowledge of the potential therapeutic benefits of marijuana when used for medical purposes.”

Iowa Announces First and Only License for Medical Marijuana Manufacturer. The Department of Public Health announced Tuesday it will issue a CBD manufacturing license to MedPharm Iowa. That is the 1st license to grow marijuana and create CBD products in the state and the only one that will be issued.

Heroin and Prescription Opioids

DEA to Open First New Field Office in 20 Years to Fight Epidemic. At a press conference last Wednesday addressing the opioid crisis, Attorney General Jeff Sessions announced that the DEA will open a new field office in Louisville, its first new field office in two decades. Sessions also announced new federal grants totaling $12-M to fund anti-heroin task forces and said that all 94 US attorneys across the country would name officials to coordinate opioid enforcement operations in their areas.

(This article was prepared by’s lobbying arm, the Drug Reform Coordination Network, which also pays the cost of maintaining this web site. DRCNet Foundation takes no positions on candidates for public office, in compliance with section 501(c)(3) of the Internal Revenue Code, and does not pay for reporting that could be interpreted or misinterpreted as doing so.)

Paul Ebeling, Editor

Have a terrific week

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :